Literature DB >> 3043799

Regulation of gene expression in lectin-stimulated or lymphokine-stimulated T lymphocytes. Effects of cyclosporine.

J C Reed1, M B Prystowsky, P C Nowell.   

Abstract

The effects of cyclosporine were examined on gene expression induced in T lymphocytes by mitogenic lectins and interleukin 2 (IL-2). Used at concentrations that inhibited proliferation of human peripheral blood lymphocytes by approximately 90%, CsA suppressed, to different extents, the phytohemagglutinin-stimulated expression of various genes, with levels of mRNAs for IL-2 being inhibited by approximately 100%, c-myc and N-ras by approximately 80%, and c-fos and IL-2 receptors by approximately 50%. Comparisons of the actions of CsA on gene expression in a cloned murine T cell (L2), stimulated with concanavalin A or IL-2, demonstrated that CsA specifically blocked the accumulation of mRNAs for the c-myc and p53 protooncogenes when induced by Con A, but not when induced by IL-2. Taken together, these findings indicate that several pathways can control the expression of a particular gene, and suggest that CsA interferes with only some of these regulatory pathways of gene expression in T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043799     DOI: 10.1097/00007890-198808001-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells.

Authors:  A Zmuidzinas; H J Mamon; T M Roberts; K A Smith
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

2.  Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes.

Authors:  Gavin C Preston; Linda V Sinclair; Aneesa Kaskar; Jens L Hukelmann; Maria N Navarro; Isabel Ferrero; H Robson MacDonald; Victoria H Cowling; Doreen A Cantrell
Journal:  EMBO J       Date:  2015-07-01       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.